Avalo Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Avalo Therapeutics, Inc.‘s stocks are currently a part of 13 hedge funds’ portfolios, which represents 2.18% of the total amount of its stocks outstanding. This makes up a total of 205.43K shares of Avalo Therapeutics, Inc.. Compared to the previous quarter, the number fell by -96.30% or -5.34M shares fewer. As for the holding position changes, 15.38% (2) of current hedge fund investors increased the number of shares held, 30.77% (4) of current holders sold a part of the shares held, and 23.08% (3) closed the holdings completely. 3 hedge funds are new holders of Avalo Therapeutics, Inc. stock in Q1 2023, it is 23.08% of total holders.
Hedge funds holding Avalo Therapeutics (Q3 2021 – Q1 2023)
Q3 2021 | 73 |
---|---|
Q4 2021 | 71 |
Q1 2022 | 64 |
Q2 2022 | 43 |
Q3 2022 | 17 |
Q4 2022 | 26 |
Q1 2023 | 13 |
Hedge funds changes in Avalo Therapeutics positions (Q3 2021 – Q1 2023)
Q3 2021 | 73 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q4 2021 | 13 | 30 | 14 | 15 | -1 |
Q1 2022 | 8 | 12 | 29 | 15 | 0 |
Q2 2022 | 9 | 7 | 18 | 29 | -20 |
Q3 2022 | 17 | 0 | 0 | 42 | -42 |
Q4 2022 | 10 | 4 | 6 | 1 | 5 |
Q1 2023 | 3 | 2 | 4 | 3 | 1 |
Hedge funds changes in Avalo Therapeutics stock options (Q3 2021 – Q1 2023)
Q3 2021 | 210,000 | 229,000 |
---|---|---|
Q4 2021 | 143,000 | 100,000 |
Q1 2022 | 6,000 | 12,000 |
Q2 2022 | 7,000 | 0 |
Q3 2022 | 6,000 | 0 |
Q4 2022 | 1,000 | 509 |
Q1 2023 | 0 | 0 |